Annaida
3 known investors
Annaida develops an AI-driven metabolomic platform using microscale magnetic resonance spectroscopy (MRS) to noninvasively analyze embryos and oocytes and support embryo selection. It serves fertility clinics and researchers with metabolic screening for personalized fertility treatments.
AI & Machine LearningFemTechMedical Devices